Fibromyalgia is among the many different chronic pain issues, and it is tough to treat. The damaging effects of opioids make many people avoid the potent painkillers. So, as per a recent study from Michigan Medicine, numerous fibromyalgia patients find cannabidiol an effective opioid alternative.
There are several CBD pain relief products available in the market, so you are unlikely to be short of options. That is partly because hemp CBD is no longer part of Schedule I of controlled substances. Cannabidiol is way less harmful as compared to tetrahydrocannabinol because it is not intoxicating and people are less likely to misuse it. If users can experience the same pain relief without tetrahydrocannabinol’s negative effects, then cannabidiol may be a useful harm reduction option.
University of Michigan’s Kevin Boehnke and other professionals surveyed fibromyalgia patients regarding their utilization of CBD dosage for pain treatment. As for Boehnke, treating fibromyalgia is not easy, as it tends to involve many standard drugs with modest benefits and major side effects. Moreover, Boehnke said that insurance does not cover alternative treatment options such as massage and acupuncture.
For the said study, Boehnke and the others concentrated on 878 fibromyalgia patients for more insights into how those people used cannabidiol goods. They discovered that over 70% of those patient-participants swapped opioids for CBD or other treatment options for pain. Many of those patients reported that it reduced or stopped not only their opioid use but other pain medicine as well.
Boehnke did not see such a level of replacement coming, and he noted that it is like the rate of substitution mentioned in medical marijuana literature. Individuals who used cannabidiol items with THC content also had not only greater odds of replacement but also more symptom relief.
Nevertheless, as for Boehnke, that CBD isolates relieved pain and replaced pain medication is a promising discovery, which merits further research. As for the researchers, much of cannabidiol’s widespread utilization occurs with no guidance from physicians and no pertinent clinical trials. Despite the lack of clinical evidence, individuals use cannabidiol in place of medication. As for Boehnke, using cannabidiol thus is not just less harmful but also more effective.
Boehnke highlighted the requirement for further controlled studies on how cannabidiol might offer the said benefits, plus whether the perks might be associated with placebo.